Overexpression of hypoxia-inducible factor-1α predicts an unfavorable outcome in urothelial carcinoma of the upper urinary tract

International Journal of Urology

Volumn 15, Issue 3, 2008, Pages 200-205

  Ke, Hung Lung ^a   Wei, Yu Ching ^b   Yang, Sheau Fang ^a   Li, Ching Chia ^a   Wu, Deng Chyang ^a   Huang, Chun Hsiung ^a,c   Wu, Wen Jeng ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Hypoxia; Hypoxia inducible factor 1 ; Prognosis; Tumor necrosis; Upper urinary tract cancer; Urothelial carcinoma

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PELVIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; URETER CARCINOMA; URINARY TRACT; UROLITHIASIS;

EID: 39849100248     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2007.01978.x     Document Type: Article

References (32)

1. 1 Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem. Sci. 1999 ; 24: 68–72.
2. 2 Semenza GL. Perspectives on oxygen sensing. Cell 1999 ; 98: 281–4.
3. 3 Wang GL, Semenza GL. General involvement of hypoxia‐inducible factor 1 in transcriptional response to hypoxia. Proc. Natl Acad. Sci. USA 1993 ; 90: 4304–8.
4. 4 Wang GL, Semenza GL. Purification and characterization of hypoxia‐inducible factor 1. J. Biol. Chem. 1995 ; 270: 1230–7.
5. 5 Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia‐inducible factor 1 is a basic‐helix‐loop‐helix‐PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA 1995 ; 92: 5510–14.
6. 6 Huang LE, Arany Z, Livingston DM, Bunn HF. Activation of hypoxia‐inducible transcription factor depends primarily upon redox‐sensitive stabilization of its alpha subunit. J. Biol. Chem. 1996 ; 271: 32 253–9.
7. 7 Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia‐inducible factor 1alpha is a marker for an unfavorable prognosis in early‐stage invasive cervical cancer. Cancer Res. 2000 ; 60: 4693–6.
8. 8 Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G. Expression of hypoxia‐inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin. Cancer Res. 2001 ; 7: 1661–8.
9. 9 Bos R, van der Groep P, Greijer AE et al. Levels of hypoxia‐inducible factor‐1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 2003 ; 97: 1573–81.
10. 10 Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL. Expression of hypoxia‐inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 2000 ; 88: 2606–18.
11. 11 Giatromanolaki A, Koukourakis MI, Sivridis E et al. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non‐small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br. J. Cancer 2001 ; 85: 881–90.
12. 12 Theodoropoulos VE, Lazaris A, Sofras F et al. Hypoxia‐inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur. Urol. 2004 ; 46: 200–8.
13. 13 Nakanishi K, Hiroi S, Tominaga S et al. Expression of hypoxia‐inducible factor‐1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract. Clin. Cancer Res. 2005 ; 11: 2583–90.
14. 14 Williams CB, Mitchell JP. Carcinoma of the ureter–a review of 54 cases. Br. J. Urol. 1973 ; 45: 377–87.
15. 15 Williams CB, Mitchell JP. Carcinoma of the renal pelvis: a review of 43 cases. Br. J. Urol. 1973 ; 45: 370–76.
16. 16 Chou YH, Huang CH. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer 1999 ; 85: 1342–4.
17. 17 Reitelman C, Sawczuk IS, Olsson CA, Puchner PJ, Benson MC. Prognostic variables in patients with transitional cell carcinoma of the renal pelvis and proximal ureter. J. Urol. 1987 ; 138: 1144–5.
18. 18 Langner C, Hutterer G, Chromecki T, Leibl S, Rehak P, Zigeuner R. Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract. J. Urol. 2006 ; 176: 910–13.
19. 19 Tomes L, Emberley E, Niu Y et al. Necrosis and hypoxia in invasive breast carcinoma. Breast Cancer Res. Treat. 2003 ; 81: 61–9.
20. 20 Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol. 1998 ; 22: 1435–48.
21. 21 Greene FL, Page DL, Fleming ID, Fritz GF, Balch CM, Haller DG, Morrow M. Renal pelvis and ureter. American Joint Committee on Cancer: AJCC Cancer Staging Manual, 6th edn. Springer, New York, 2002 ; 329–34.
22. 22 Rajakumar A, Conrad KP. Expression, ontogeny, and regulation of hypoxia‐inducible transcription factors in the human placenta. Biology Reprod 2000 ; 63: 559–69.
23. 23 Zhong H, De Marzo AM, Laughner E et al. Overexpression of hypoxia‐inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999 ; 59: 5830–35.
24. 24 Koukourakis MI, Giatromanolaki A, Liberis V, Sivridis E. Hypoxia inducible factor 1 alpha and 2 alpha expression is independent of anemia in patients with stage I endometrial cancer. Anticancer Res. 2002 ; 22: 4137–40.
25. 25 Koukourakis MI, Giatromanolaki A, Sivridis E et al. Hypoxia‐inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head‐and‐neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2002 ; 53: 1192–202.
26. 26 Schumacker PT. Hypoxia‐inducible factor‐1 (HIF‐1). Crit. Care Med. 2005 ; 33: S423–5.
27. 27 Haddad JJ, Harb HL. Cytokines and the regulation of hypoxia‐inducible factor (HIF) ‐1alpha. Int. Immunopharmacol. 2005 ; 5: 461–83.
28. 28 Jones A, Fujiyama C, Blanche C et al. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia‐inducible factor‐1 alpha and hypoxia‐inducible factor‐2 alpha in human bladder tumors and cell lines. Clin. Cancer Res. 2001 ; 7: 1263–72.
29. 29 Kondo Y, Hamada J, Kobayashi C et al. Overexpression of hypoxia‐inducible factor‐1alpha in renal and bladder cancer cells increases tumorigenic potency. J. Urol. 2005 ; 173: 1762–6.
30. 30 Theodoropoulos VE, Lazaris AC, Kastriotis I et al. Evaluation of hypoxia‐inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma. BJU Int. 2005 ; 95: 425–31.
31. 31 Zhou JT, Cai ZM, Li NC, Na YQ. [Expression of hypoxia inducible factor‐1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof]. Zhonghua Yi Xue Za Zhi 2006 ; 86: 1970–4.
32. 32 An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization of wild‐type p53 by hypoxia‐inducible factor 1alpha. Nature 1998 ; 392: 405–8.